1 option
HER2 testing to manage patients with breast cancer or other solid tumors / prepared by Blue Cross and Blue Shield Association, Technology Evaluation Center Evidence-based Practice Center ; investigators, Jerome Seidenfeld [and others].
- Format:
- Book
- Government document
- Series:
- Evidence report/technology assessment ; no. 172.
- AHRQ publication ; no. 09-E 001.
- Evidence report/technology assessment ; no. 172
- AHRQ publication ; no. 09-E 001
- Language:
- English
- Subjects (All):
- HER-2 gene.
- Breast--Cancer--Gene therapy.
- Breast.
- Genes, erbB-2--genetics.
- Neoplasms--genetics.
- Antibodies, Monoclonal--therapeutic use.
- Antineoplastic Agents--therapeutic use.
- Genetic Testing--methods.
- Neoplasms--drug therapy.
- Genes, erbB-2.
- Medical Subjects:
- Genes, erbB-2--genetics.
- Neoplasms--genetics.
- Antibodies, Monoclonal--therapeutic use.
- Antineoplastic Agents--therapeutic use.
- Genetic Testing--methods.
- Neoplasms--drug therapy.
- Genes, erbB-2.
- Physical Description:
- x, 350 pages : digital, PDF file.
- Place of Publication:
- [Rockville, Md.] : [Agency for Healthcare Research and Quality], [2008]
- Notes:
- Title from title screen (viewed on Feb. 2, 2009).
- "November 2008."
- Includes bibliographical references (pages 161-171).
- "Contract no. 290-02-0026."
- OCLC:
- 301351975
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.